Huanan Wang

Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo

During the process of bone regeneration, a multitude of morphogenetic signaling factors regulate cellular behavior and ultimately tissue response. These factors are presented to cells under strong spatial and temporal control, which stresses the relevance of controlled delivery of multiple growth factors for bone tissue regeneration. This demand for biomimetic delivery has prompted the development of a novel generation of biomaterials that is capable of delivering multiple growth factors in a controlled manner. Therefore, the current study has exploited the strong capacity of colloidal gels solely made of oppositely charged gelatin nanospheres to obtain controlled release of angiogenic and osteogenic growth factors. The release kinetics of dual delivery of osteogenic bone morphogenetic protein-2 (BMP-2) and angiogenic basic fibroblast growth factor (bFGF) were investigated in vitro by radiolabeling the respective growth factors and monitoring their release in vitro. Furthermore, the effect of single or dual delivery of BMP-2 and bFGF on bone regeneration was evaluated in vivo using a rat femoral condyle defect model. The in vitro results confirmed that the delivery kinetics of BMP-2 and/or bFGF are more dependent on the degree of crosslinking than on the type of gelatin. Sequential release characterized by rapid release of angiogenic bFGF and more sustained release of BMP-2 was obtained by loading bFGF onto cationic nanospheres of low crosslinking density and BMP-2 onto anionic nanospheres of high crosslinking density. The in vivo study demonstrated the biocompatibility and biodegradability of bare colloidal gelatin gels, and did not show any adverse effects on the process of bone healing after 4 week of implantation since the volumes of new bone formation were comparable to empty control defects. An obvious stimulatory effect on bone regeneration was observed for the colloidal gels loaded with BMP-2, whereas bFGF-loaded colloidal gelatin gels did not influence the rate of bone regeneration. In contrast, the combined delivery of BMP-2 and bFGF resulted into an inhibitory effect on osteogenesis under the current experimental conditions. Summarizing, the current study proved that nanostructured colloidal gelatin gels are suitable carriers for programmed and sustained release of multiple therapeutic proteins for tissue regeneration.

Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats

The design of bioactive three-dimensional (3D) scaffolds is a major focus in bone tissue engineering. Incorporation of growth factors into bioprinted scaffolds offers many new possibilities regarding both biological and architectural properties of the scaffolds. This study investigates whether the sustained release of bone morphogenetic protein 2 (BMP-2) influences osteogenicity of tissue engineered bioprinted constructs. BMP-2 loaded on gelatin microparticles (GMPs) was used as a sustained release system, which was dispersed in hydrogel-based constructs and compared to direct inclusion of BMP-2 in alginate or control GMPs. The constructs were supplemented with goat multipotent stromal cells (gMSCs) and biphasic calcium phosphate to study osteogenic differentiation and bone formation respectively. BMP-2 release kinetics and bioactivity showed continuous release for three weeks coinciding with osteogenicity. Osteogenic differentiation and bone formation of bioprinted GMP containing constructs were investigated after subcutaneous implantation in mice or rats. BMP-2 significantly increased bone formation, which was not influenced by the release timing. We showed that 3D printing of controlled release particles is feasible and that the released BMP-2 directs osteogenic differentiation in vitro and in vivo.

Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: Bone morphogenetic protein-2 and alkaline phosphatase

Colloidal gels have recently emerged as a promising new class of materials for regenerative medicine by employing micro- and nanospheres as building blocks to assemble into integral scaffolds. To this end, physically crosslinked particulate networks are formed that are injectable yet cohesive. By varying the physicochemical properties of different particle populations, the suitability of colloidal gels for programmed delivery of multiple therapeutic proteins is superior over conventional monolithic gels that lack this strong capacity for controlled drug release. Colloidal gels made of biodegradable polymer micro- or nanospheres have been widely investigated over the past few years, but a direct comparison between micro- vs. nanostructured colloidal gels has not been made yet. Therefore, the current study has compared the viscoelastic properties and capacity for drug release of colloidal gels made of oppositely charged gelatin microspheres vs. nanospheres. Viscoelastic properties of the colloidal gelatin gels were characterized by rheology and simple injectability tests, and in vitro release of two selected osteogenic proteins (i.e. bone morphogenetic protein-2 (BMP-2) and alkaline phosphatase (ALP)) from the colloidal gelatin gels was evaluated using radiolabeled BMP-2 and ALP. Nanostructured colloidal gelatin gels displayed superior viscoelastic properties over microsphere-based gels in terms of elasticity, injectability, structural integrity, and self-healing behavior upon severe network destruction. In contrast, microstructured colloidal gelatin gels exhibited poor gel strength and integrity, unfavorable injectability, and did not recover after shearing, resulting from the poor gel cohesion due to insufficiently strong interparticle forces. Regarding the capacity for drug delivery, sustained growth factor (BMP-2) release was obtained for both micro- and nanosphere-based gels, the kinetics of which were mainly depending on the particle size of gelatin spheres with the same crosslinking density. Therefore, the optimal gelatin carrier for drug delivery in terms of particle size and crosslinking density still needs to be established for specific clinical indications that require either short-term or long-term release. It can be concluded that nanostructured colloidal gelatin gels show great potential for sustained delivery of therapeutic proteins, whereas microstructured colloidal gelatin gels are not sufficiently cohesive as injectables for biomedical applications.

Oppositely charged gelatin nanospheres as building blocks for injectable and biodegradable gels

www.MaterialsViews.com C O M M Oppositely Charged Gelatin Nanospheres as Building Blocks for Injectable and Biodegradable Gels U N IC A T Huanan Wang , Morten B. Hansen , Dennis W. P. M. Lowik , Jan C. M. van Hest , Yubao Li , John A. Jansen , and Sander C. G. Leeuwenburgh * IO N The emergence of regenerative medicine has led to a paradigm shift in the design of novel biomaterials, which are now increasingly considered as (bio)active scaffolds that induce tissue regeneration as opposed to the more traditional concept of passively accepted implant materials. [ 1 ] In order to present biological stimuli to the physiological environment and to trigger tissue repair, optimal integration of synthetic biomaterials within the surrounding tissue is of paramount importance. In that respect, hydrogels made from biodegradable polymers are ideal candidates, since they are generally biocompatible, biodegradable, and, in some cases, injectable. [ 2–4 ] In addition, polymeric hydrogels can act as a reservoir for sustained release of therapeutic and signaling agents. [ 4 ] Nevertheless, current gelbased materials exhibit a rather poor ability to present multiple signaling molecules at programmed time-points and release rates. Colloidal gels, on the other hand, have recently been identifi ed as a promising “bottom-up” strategy for the design of highly functional scaffolds by employing microor nanometer-scale particles as building blocks to assemble into shape-specifi c bulk materials. [ 5–13 ] To this end, interparticle interactions such as electrostatic forces, [ 14 ] magnetic forces, [ 14 ] hydrophobic interactions [ 15 ] and steric hindrance [ 16 ] can be exploited to induce selfassembly of microor nanoparticles into integrated scaffolds. By incorporation of bioactive agents (e.g., enzymes, growth factors and/or biomineral nanocrystals) into these particulate building blocks of variable biodegradability, injectable gels with micrometer-scale resolution and complexity can be formed. This new class of materials would offer virtually unlimited degree of freedom with respect to their capacity for programmed drug release of multiple biomolecules at predetermined release rates. Charged polymeric microor nanospheres are the most obvious building blocks for the design of such injectable and

Biomimetic spiral-cylindrical scaffold based on hybrid chitosan/cellulose/nano-hydroxyapatite membrane for bone regeneration.

Natural bone is a complex material with well-designed architecture. To achieve successful bone integration and regeneration, the constituent and structure of bone-repairing scaffolds need to be functionalized synergistically based on biomimetics. In this study, a hybrid membrane composed of chitosan (CS), sodium carboxymethyl cellulose (CMC), and nano-hydroxyapatite (n-HA) was curled in a concentric manner to generate an anisotropic spiral-cylindrical scaffold, with compositional and structural properties mimicking natural bone. After optimization in terms of morphology, hydrophilicity, swelling and degradation pattern, the osteoblast cells seeded on the membrane of 60 wt% n-HA exhibited the highest cell viability and osteocalcin expression. In vivo osteogenesis assessment revealed that the spiral-cylindrical architecture played a dominant role in bone regeneration and osseointegration. Newly formed bone tissue grew through the longitudinal direction of the cylinder-shaped scaffold bridging both ends of the defect, bone marrow penetrated the entire scaffold and formed a medullary cavity in the center of the spiral cylinder. This study for the first time demonstrates that the spiral-cylindrical scaffold can promote complete infiltration of bone tissues in vivo, leading to successful osteointegration and functional reconstruction of bone defects. It suggests that the biomimetic spiral-cylindrical scaffold could be a promising candidate for bone regeneration applications.

Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration.

Gelatin microspheres are well-known for their capacity to release growth factors in a controlled manner, but gelatin microspheres do not calcify in the absence of so-called bioactive substances that induce deposition of calcium phosphate (CaP) bone mineral. This study has investigated if CaP nanocrystals can be incorporated into gelatin microspheres to render these inert microspheres bioactive without compromising the drug releasing properties of gelatin microspheres. Incorporation of CaP nanocrystals into gelatin microspheres resulted into reduced biodegradation and drug release rates, whereas their calcifying capacity increased strongly compared to inert gelatin microspheres. The reduced drug release rate was correlated to the reduced degradation rate as caused by a physical cross-linking effect of CaP nanocrystals dispersed in the gelatin matrix. Consequently, these composite microspheres combine beneficial drug-releasing properties of organic gelatin with the calcifying capacity of a dispersed CaP phase.

Local delivery of small and large biomolecules in craniomaxillofacial bone.

Current state of the art reconstruction of bony defects in the craniomaxillofacial (CMF) area involves transplantation of autogenous or allogenous bone grafts. However, the inherent drawbacks of this approach strongly urge clinicians and researchers to explore alternative treatment options. Currently, a wide interest exists in local delivery of biomolecules from synthetic biomaterials for CMF bone regeneration, in which small biomolecules are rapidly emerging in recent years as an interesting adjunct for upgrading the clinical treatment of CMF bone regeneration under compromised healing conditions. This review highlights recent advances in the local delivery small and large biomolecules for the clinical treatment of CMF bone defects. Further, it provides a perspective on the efficacy of biomolecule delivery in CMF bone regeneration by reviewing presently available reports of pre-clinical studies using various animal models.

Highly Elastic and Self‐Healing Composite Colloidal Gels

Composite colloidal gels are formed by the pH-induced electrostatic assembly of silica and gelatin nanoparticles. These injectable and moldable colloidal gels are able to withstand substantial compressive and tensile loads, and exhibit a remarkable self-healing efficiency. This study provides new, critical insight into the structural and mechanical properties of composite colloidal gels and opens up new avenues for practical application of colloidal gels.